Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib. Issue 2 (1st March 2016) - Selaru, P; Tang, Y; Huang, B; Polli, A; Wilner, KD; Donnelly, E; Cohen, DP